Gabriel Schnetzler - Concepedia

Author

Gabriel Schnetzler

Pfizer (United Kingdom)ORCID

Also Known As

G Schnetzler, G. Schnetzler, Gabriel Schnetzler

Publications

617

Citations

H-Index

Concepts

All Affiliations

Pfizer (United Kingdom)Pfizer (United States)Roche (Switzerland)Pfizer (France)University of Zurich

About

Gabriel Schnetzler is an author at Pfizer (United Kingdom) specializing in medicine, social sciences, and gender identity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	216
2	Social Sciences	1	1	14
3	Gender Studies	1	1	14
4	Immunology	1	1	199
5	Pharmacology	1	1	17

Gabriel Schnetzler

Publications

544

Citations

H-Index

Page 1

	Year	Citations
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults Thomas M. Kündig, Gabriela Senti, Gabriel Schnetzler, Journal of Allergy and Clinical Immunology VaccinationViral PathogenesisImmunologyAntiviral ResponseVirology	2006	199
Original Research—ED Pharmacotherapy: Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors Gabriel Schnetzler, Ian Banks, Mike Kirby, The Journal of Sexual Medicine	2010	58
Emotional Changes in Men Treated With Sildenafil Citrate for Erectile Dysfunction: A Double-Blind, Placebo-Controlled Clinical Trial Ignacio Moncada, J.M. Martínez-Jabaloyas, L. Rodríguez-Vela, The Journal of Sexual Medicine	2009	32
Interrelationship of Sildenafil Treatment Effects on the Physiological and Psychosocial Aspects of Erectile Dysfunction of Mixed or Organic Etiology Stanley E. Althof, Michael M. Berner, Irwin Goldstein, The Journal of Sexual Medicine	2010	32
Scoring Correspondence in Outcomes Related to Erectile Dysfunction Treatment on a 4-Point Scale (SCORE-4) Joseph C. Cappelleri, Andrew G. Bushmakin, Tara Symonds, The Journal of Sexual Medicine	2009	31
Induction of the IL-10 gene via the Fas receptor in monocytes - an anti-inflammatory mechanism in the absence of apoptosis Isabelle Daigle, Beate Rückert, Gabriel Schnetzler, European Journal of Immunology	2000	23
Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia Isabelle Arnet, Matthias Altermatt, Yves Roggo, Journal of Chemotherapy	2014	22
Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab Christina Theodore‐Oklota, L. Humphrey, C. Wiesner, Patient Preference and Adherence	2016	19
Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor Jürgen Wichmann, Caroline Rynn, Thomas Friess, Clinical Cancer Research	2021	18
Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study Mike Kirby, Gabriel Schnetzler, Kelly H. Zou, International Journal of Clinical Practice	2011	17

Page 1